BodyBoost testimonials
Hear directly from people who experienced BodyBoost.
Explore firsthand perspectives on BodyBoost technology, then arrange a demonstration for your own team.
Request a Demo
SolaJet in a commercial facility setting
New case study
A closer look at one TheraJet session.
Explore two VasioCore® measurement reports from a London event, with the recorded results and the limits of a single-person observation.
Testimonials
See what people felt for themselves.
Choose any testimonial to watch it full screen, then swipe or scroll through the collection.
6 of 22
These are individual experiences. Personal results vary and are not a guarantee of outcomes.
Case study | London, September 2026
TheraJet: a single-session case study.
A look at two VasioCore® reports taken before and after a reported 10-minute, full-body TheraJet session at a London biohacking conference.
What was recorded
The reports are dated September 11, 2026, at 12:58 and 14:10. The supplied case summary describes a TheraJet session between the measurements. The later report recorded lower average blood pressure, flow resistance index and aortic input impedance, alongside a higher wall compliance index.
This is a single-person observation, without a control group. It cannot establish that TheraJet caused the differences, that they persist, or that other users would experience the same results.
| Measurement | First reading 12:58 | Later reading 14:10 |
|---|---|---|
| Average brachial blood pressure (mmHg) | 138 / 69 | 130 / 67 |
| Average aortic blood pressure (mmHg) | 122 / 69 | 115 / 69 |
| Heart rate (beats/min) | 71 | 68 |
| Wall Compliance Index | 0.42 | 0.52 |
| Flow Resistance Index | 27.2 | 19.4 |
| Aortic Input Impedance Index | 241 | 200 |
| Calculated vascular age (years) | 64 | 50 |
| Estimated aortic pulse-wave velocity (m/s) | 8.2 | 8.5 |
| Augmentation Index (%) | 14.0 | 14.3 |
| Heart-rate-adjusted Augmentation Index (%) | 12.1 | 11.0 |
| Estimated cardiac output (L/min) | 7.2 | 6.9 |
| Estimated stroke volume (mL) | 85 | 86 |
| dp/dtmax (mmHg/s) | 1,547 | 1,465 |
Reading the results in context
The calculated vascular-age estimate changed from 64 to 50. This is a device-derived estimate of vascular state, not evidence that 14 years of biological aging were reversed. The reports caution against using vascular age in isolation.
Not every measure moved in the same direction. Estimated aortic pulse-wave velocity increased from 8.2 to 8.5 m/s, while augmentation index was almost unchanged. The table includes these results for balance.
Repeated measurements under standardized conditions and controlled research would be needed to assess reproducibility, cause and duration. These observations are not a treatment claim or a guarantee of health outcomes.
Source and scope
Adapted from VasioCore Case Study 926, supplied by Todd Howe of SolaJet, and checked against the two accompanying VasioCore® measurement reports from inmediQ GmbH.
The source describes the session as TheraJet. These findings have not been established for BodyBoost’s SolaJet® or AquaVive™ systems.
This public summary omits participant identifiers. It presents selected central measurements; it is not the complete medical report. Reviewed September 17, 2026.
Experience the products yourself
Bring the decision-makers to the demonstration.
We will review your setting and select the right system to demonstrate before explaining the monthly rental.
Quick guide
How to read these testimonials
These videos document individual experiences with Bodyboost systems. They help a facility understand the experience, but they are not proof of typical medical, utilization or financial outcomes.
- Designed for
- Decision-makers who want to see firsthand product reactions before arranging a demonstration.
- Service area
- Seattle & Bellevue, Washington
- What to do next
- Request product guidance, rental information or a demonstration.